Vitamin K1
NDC Package 50090-4523-0

11-digit billing NDC: 50090452300

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Vitamin K1 is injection (Phytonadione Injectable Emulsion, USP) is indicated in the following coagulation disorders which are due to faulty formation of factors II, VII, IX and X when caused by vitamin K deficiency or interference with vitamin K activity.Vitamin K1 Injection is indicated in:anticoagulant-induced prothrombin deficiency caused by coumarin or indanedione derivatives;prophylaxis and therapy of hemorrhagic disease of the newborn;hypoprothrombinemia due to antibacterial therapy;hypoprothrombinemia secondary to factors limiting absorption or synthesis of vitamin K, e.g., obstructive jaundice, biliary fistula, sprue, ulcerative colitis, celiac disease, intestinal resection, cystic fibrosis of the pancreas, and regional enteritis;other drug-induced hypoprothrombinemia where it is definitely shown that the result is due to interference with vitamin K metabolism, e.g., salicylates. Marketed by A-s Medication Solutions, this product is identified by NDC 50090-4523 and is authorized under FDA application ANDA087954.

Identification & Billing

NDC Package Code
50090-4523-0
Package Description
.5 mL in 1 AMPULE
Product Code
11-Digit Billing Format
50090452300
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Vitamin K1
Dosage Form
-
Usage Information
Vitamin K1 Injection (Phytonadione Injectable Emulsion, USP) is indicated in the following coagulation disorders which are due to faulty formation of factors II, VII, IX and X when caused by vitamin K deficiency or interference with vitamin K activity.Vitamin K1 Injection is indicated in:anticoagulant-induced prothrombin deficiency caused by coumarin or indanedione derivatives;prophylaxis and therapy of hemorrhagic disease of the newborn;hypoprothrombinemia due to antibacterial therapy;hypoprothrombinemia secondary to factors limiting absorption or synthesis of vitamin K, e.g., obstructive jaundice, biliary fistula, sprue, ulcerative colitis, celiac disease, intestinal resection, cystic fibrosis of the pancreas, and regional enteritis;other drug-induced hypoprothrombinemia where it is definitely shown that the result is due to interference with vitamin K metabolism, e.g., salicylates.

Regulatory & Marketing

Labeler Name
A-s Medication Solutions
FDA Application #
ANDA087954
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
06-22-2005
Listing Expiration
12-31-2022
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50090-4523-0 identifies a specific commercial package of .5 ml in 1 ampule of Vitamin K1, labeled by A-s Medication Solutions. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by A-s Medication Solutions on June 22, 2005. The current certification is valid through December 31, 2022.

How is this A-s Medication Solutions product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50090452300. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
50090-4523-0
11-Digit CMS (5-4-2)
50090-4523-00

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.